Literature DB >> 9061430

An unusual case of Bellini duct carcinoma.

M I Anjum1, P Y Ting, N Shrotri, B Randall, G R Mufti.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 9061430     DOI: 10.1007/bf02552166

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  6 in total

1.  Distal nephron carcinoma: a rare kidney tumor.

Authors:  E Becht; S C Müller; S Störkel; P Alken
Journal:  Eur Urol       Date:  1988       Impact factor: 20.096

2.  Atypical carcinoma of kidney originating from collecting duct epithelium.

Authors:  M A Hai; R Diaz-Perez
Journal:  Urology       Date:  1982-01       Impact factor: 2.649

3.  Bellini duct carcinoma: further evidence for this rare variant of renal cell carcinoma.

Authors:  H J Rumpelt; S Störkel; R Moll; T Schärfe; W Thoenes
Journal:  Histopathology       Date:  1991-02       Impact factor: 5.087

4.  Atypical carcinoma of kidney: possibly originating from collecting duct epithelium.

Authors:  W J Cromie; C J Davis; F A DeTure
Journal:  Urology       Date:  1979-03       Impact factor: 2.649

5.  Bellini duct carcinoma of the kidney.

Authors:  Y Koikawa; N Sakamoto; S Naito; M Tanaka; T Ueda; J Kumazawa
Journal:  Eur Urol       Date:  1992       Impact factor: 20.096

6.  Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins.

Authors:  H Holthöfer; A Miettinen; R Paasivuo; V P Lehto; E Linder; O Alfthan; I Virtanen
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

  6 in total
  1 in total

1.  Inhibition of pleural metastasis of collecting duct carcinoma of the kidney by modified cytokine-induced killer cells: A case report and review of the literature.

Authors:  Jingyi Liu; Jun Sui; Zhiwei Zhang; Xiubao Ren; Li Luan; Qisheng Yang; Songhai Gu; Rudolf Wank; Barbara Laumbacher; Xin Song
Journal:  Oncol Lett       Date:  2010-09-08       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.